Invitrogen™ CEA Human ELISA Kit

Ref.: BL-RE-093577Manufacturer ref.: EHCEAX5 5 x 96 tests
€2,950.00 excl. VAT

Kit ELISA Carcino Embryonic Antigen sandwich (Hu CEA) (human): quantitative determination of Hu CEA in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CEA.

Accession number
P06731
Dose range
0.343 ng/ml to 250 ng/ml
Sensitivity of the dosage
200 pg/ml
Calibration range
0.2 ng/ml to 250 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen

Kit ELISA Carcino Embryonic Antigen sandwich (Hu CEA) (human): quantitative determination of Hu CEA in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CEA.

Kit ELISA Carcino Embryonic Antigen sandwich (Hu CEA) (human): quantitative determination of Hu CEA in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CEA.

Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.

Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).

The carcinoembryonic antigen CD66e (CEA) is synthesized in the intestine of the foetus during development and is again expressed in higher amounts in the intestinal carcinomas and several other tumours. The CEA is a member of the family of immunoglobulin supergens, carcinoembryonic antigens, and consists of a single domain N (structural homology on the variable d-immunoglobulin) and six domains of constant-type immunoglobulin A (A1, A2, A3) and B (B1, B2, B3). The ACE antibodies are useful in identifying the origin of the various metastatic adenocarcinomas and distinguishing between pulmonary adenocarcinomas (60-70% are CEA+) and pleural mesotheliomas (rarely or weakly CEA+). CEA is part of the large glycoprotein family, a tumour marker useful for adenocarcinoma, and found in the epithelium adenocarcinomas of the digestive system derived from lhe endoderma and the colon of the foetus. Two subgroups of the CEA family, CEA cell adhesion molecules and pregnancy-specific glycoproteins, are located in a 1.2 Mb group on the long arm of chromosome 19. Eleven pseudogenes from the CEA cell adhesion molecules subgroup are also present in the group. CEA was initially described in the liver bile canals as biliary glycoprotein. Subsequently, it was shown that CEA is a cell adhesion molecule detected on leukocytes, l'épithelium, and l'endothelium. The coded protein allows cell adhesion to be mediated by homophilic bonding and heterophilic bonding to other proteins in the subgroup. Several cellular activities were attributed to coded protein, including roles in differentiation and arrangement of the three-dimensional structure of tissues, Several transcription variants coding different isoforms were recorded, but the full length nature of all variants was not defined.

Sensitivity

Sensitivity of the dosage: 200 pg/ml.

Measurement range

Dose range: 0.343 ng/ml to 250 ng/ml.

Duration of dosing

Total dosage duration: 4 hours 45 min.

Target

Target: Human.

Samples

Sample type: Plasma, Serum, Surnatant (plasma volume, 50 μl; serum, 50 μl; supernatant, 100 μl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17105399
Specifications
Accession numberP06731
Dose range0.343 ng/ml to 250 ng/ml
Sensitivity of the dosage200 pg/ml
Calibration range0.2 ng/ml to 250 ng/ml
DoseELISA solid-phase sandwich
ConjugateBiotin
Product typeKit ELISA
Protein familyCell structure & organic proteins
Type of samplePlasma, Serum, Surnatant
SpecificityThis ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF- 4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, leptin (
Sufficient for5 x 96 dosages
Target speciesHuman
For use with (application)ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)1048
Gene symbol(s)CD66e,CEA
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsDiscontinuation solution, Biotinylated detection antibody, Wash pad, 96-well pre-coated plates, Adhesive plate covers, Stall, Chromogen, Dose diluent concentrate, SAV-HRP
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusRUO
Research disciplinesExtracellular Matrix & Cell Adhesion
SynonymCD66e, CEA
TargetHuman
Test time1 hour 20 minutes.
Physical characteristics
Volume of samplePlasma, 50 μl; serum, 50 μl; supernatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4:45 a.m.

Origin and customs

Manufacturer ref.EHCEAX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.